Stocks · Health care · Pharmaceutical Preparations

Emergent BioSolutions Inc.

EBS Clue Score47
United States Fiscal year ends December CIK 0001367644 Results filed 2 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Joseph C Papa
13 May 2025
President and CEO
Buy
60,000
$5.83
$349.80K
Richard S Lindahl
15 Nov 2021
EVP, Chief Financial Officer
Buy
3,000
$37.46
$112.38K

What was left out

Form 4 filings counted 420
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 79
Sales at will 108
Transactions with no price 0
Shares from compensation/vesting 9,734,290
Sales filed before the plan box existed 97
History held since 21 Nov 2006